Several studies in experimental murine models have shown that Treg can suppress proliferative activity of conventional CD4+ T cells and CD8+ T cells to alloantigenic stimulation in vitro and induce transplantation tolerance and reduce acute GVHD occurrence in vivo [13-15]. Here, CD8A is linked to graft versus host disease.